Pediatric Heart Surgeons Propose Selection Framework to Predict Mitral Valve Repair Success in Dilated Cardiomyopathy

Children with dilated cardiomyopathy often face a devastating complication: as the left ventricle balloons outward, the mitral valve leaflets can no longer coapt properly, and blood leaks backward into the left atrium with every heartbeat. This condition, known as functional mitral regurgitation, develops in an estimated 40 to 65 percent of pediatric dilated cardiomyopathy patients and independently predicts death or the need for heart transplantation. Yet the surgical response to it has been strikingly inconsistent. Published pediatric mitral valve repair series spanning 2003 to 2024 report clinical stabilization rates ranging from zero to one hundred percent, with perioperative mortality swinging between zero and fifty percent.

A new study published in BMC Pediatrics argues that much of this bewildering heterogeneity stems from a factor that has never been systematically examined: patient selection. The research team, led by pediatric cardiologists and cardiac surgeons at Koç University Hospital in Istanbul, proposes a fully preoperative, mechanism-anchored framework designed to identify which children with severe functional mitral regurgitation are most likely to benefit from valve repair rather than proceeding directly to transplantation or mechanical circulatory support. The authors emphasize that the framework is a proof-of-concept clinical hypothesis, not a validated decision algorithm, and that prospective multicenter validation is required before any clinical adoption.

The framework classifies candidates into three categories defined a priori. Children are labeled Non-MR-dominant if any of four affirmative features are documented: a toxic, storage, infiltrative, or myopathic underlying etiology; primary structural disease of the mitral valve itself; preoperative irreversible end-organ failure or extracorporeal membrane oxygenation with multi-organ dysfunction; or severe right ventricular dysfunction, fixed pulmonary hypertension, or severe tricuspid regurgitation arising from right ventricular and annular dilatation. The logic is that in these patients, the leaking mitral valve is a downstream symptom of a broader disease process that valve repair alone cannot reverse.

Conversely, patients without any of those features who meet three volume-overload criteria are classified as MR-dominant. Those criteria are idiopathic, familial, or sarcomeric dilated cardiomyopathy; functional mitral regurgitation of at least grade 3+; and a left ventricular end-diastolic diameter Pettersen Z-score of plus five or greater. In this group, the researchers argue, the regurgitation itself becomes the dominant driver of a vicious cycle: the leak volume-loads an already weakened ventricle, causing further dilatation, worsening leaflet coaptation, and progressively more severe regurgitation. Interrupting that cycle surgically may allow the ventricle to remodel back toward a healthier geometry.

A third category, Borderline MR-dominant, captures children who do not meet all MR-dominant criteria but satisfy one of three predefined conditions: infancy with intermediate fractional shortening; post-myocarditis status with documented regional scar or a fibrotic substrate on imaging; or a left ventricular end-diastolic diameter Pettersen Z-score between plus 3.5 and less than plus 5 accompanied by severe functional regurgitation. The borderline designation acknowledges the clinical gray zone where the mechanism is plausible but the evidence is less complete, and it places these patients in an intermediate tier rather than excluding them outright.

To test the framework, the team applied it to a single-center cohort of six consecutive children. Three MR-dominant children underwent mitral valve repair and sustained ventricular remodeling, achieving transplant-free survival at a median follow-up of thirty months, with N-terminal pro-B-type natriuretic peptide, a key blood biomarker of heart failure severity, falling by 86 to 99 percent. The other three children were not selected for repair: one MR-dominant child whose family declined surgery, and two Non-MR-dominant children. All three died. The authors are careful not to overinterpret this small observational signal, but the concordance between the framework’s predictions and the observed outcomes is the study’s central proof of concept.

The researchers then took a more ambitious step: they applied the framework, masked to outcome, to all 22 previously published pediatric patients who received mitral valve repair, pooling them with their own cohort for a combined analysis of 25 patients. Among the MR-dominant and Borderline patients, clinical stabilization and/or remodeling was achieved in 16 of 20 cases, or 80 percent. Among Non-MR-dominant patients, the corresponding figure was 1 of 5, or 20 percent. The difference was statistically significant by Fisher’s exact test, with a p-value of 0.024 and an odds ratio of 11.0 with a 95 percent confidence interval of 1.3 to 91.8.

That wide confidence interval reveals the study’s most important limitation, which the authors discuss with unusual candor. The association is statistically significant in the primary specification but is fragile to single-patient reclassification, an unavoidable consequence of the fact that only five Non-MR-dominant patients have been reported across three decades of global pediatric literature. Moving a single patient between categories could materially shift the result. This transparency is itself notable in a field where small series and selective reporting have historically inflated the apparent success of surgical techniques.

The clinical implications, if the framework survives validation, could be substantial for regions where pediatric heart transplantation and durable ventricular assist device support are inaccessible or severely limited. In MR-dominant disease, the authors suggest, mitral valve repair may support clinical stabilization with the potential for reverse remodeling, offering a viable bridging strategy or even an alternative to transplantation. The framework deliberately places the burden of proof on assigning a child to the Non-MR-dominant category, inverting the traditional default of reserving surgery for the sickest or most desperate cases.

The study received no specific external funding, was approved by the Koç University Institutional Review Board, and is published open access. The authors used generative artificial intelligence tools exclusively for language editing, stating that all scientific content, data analysis, and clinical interpretation are their own. For now, the message to the pediatric cardiology community is measured: a biologically grounded, fully preoperative framework offers a coherent interpretation of three decades of contradictory outcomes, but only prospective multicenter testing can determine whether it should guide real-world surgical decisions.

Subject of Research: A preoperative selection framework for mitral valve repair in pediatric dilated cardiomyopathy with severe functional mitral regurgitation

Article Title: Mitral valve repair for pediatric dilated cardiomyopathy with severe functional mitral regurgitation: a mechanism-anchored, proof-of-concept preoperative selection framework with supportive cohort and pooled outcomes

Article References: Kizilkaya, M. H., Cakan, B., Ardali, A., Bicer, M., Tanyildiz, M., Ozden, O., & Odemis, E. (2026). Mitral valve repair for pediatric dilated cardiomyopathy with severe functional mitral regurgitation: a mechanism-anchored, proof-of-concept preoperative selection framework with supportive cohort and pooled outcomes. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07857-5

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07857-5

Keywords: dilated cardiomyopathy, mitral valve repair, functional mitral regurgitation, pediatric heart failure, patient selection framework, ventricular remodeling, pediatric cardiac surgery, heart transplantation, NT-proBNP, BMC Pediatrics, Mitral, valve